Pearl Diver Credit Co Inc. (PDCC): Management’s unaudited net asset value per share of our common stock as of August 31, 2026 was $10.86

Pearl Diver Credit Co Inc. (PDCC) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events Management’s unaudited net asset value per share of our common stock as of August 31, 2026 was $10.86. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Pearl Diver Credit Company Inc. has duly caused this report to

Original reporting
Published Sep 15, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 11:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$PDCC
Neutral
high confidence
Mentioned
$PDCC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PDCCNeutralLow
01

Why it matters

The filing provides a routine update for existing shareholders; no new catalyst for trading.

02

Market read

Low relevance; the disclosure is routine and unlikely to affect market pricing.

03

What to watch

None

Relevance 4/10Novelty 3/10Timing: filed Sep 15 2026

Background

Pearl Diver Credit Co Inc. filed a standard Form 8‑K under Item 8.01 to disclose its latest net asset value per share.

Company-level read

Ticker impact

$PDCCNeutralHigh confidence
Context

SEC 8‑K reports unaudited net asset value of $10.86 per share as of Aug 31 2026.

Expected impact

minimal

Evidence & confidence

NAV disclosure is routine and does not change valuation assumptions.

Market effects

none

none

none

Counterpoint

No contrarian angle; filing is purely informational.

Key entities

  • Pearl Diver Credit Co Inc.

    Issuer of the 8‑K filing.

Related articles

$CVSMed

CVS Health announces plan to split into two companies

CVS Health plans to split into two publicly traded companies by early 2028, separating its retail pharmacy business from Aetna and CVS Caremark. The move follows a Tennessee law targeting healthcare giants like CVS, which owns both a pharmacy benefit manager and retail pharmacies. CVS is suing the state, claiming the law is unconstitutional. The company states the restructuring will not affect its Tennessee pharmacies or clinics.

$RKLBHigh

Pentagon announces $150m conditional loans for Stoke Space and Rocket Lab

The Pentagon's Office of Strategic Capital offered $150m in conditional loans to Stoke Space and Rocket Lab for developing medium-class launch vehicles. Stoke Space will use funds for a second launch pad, while Rocket Lab aims to increase Neutron rocket production. Both companies must meet requirements to secure the loans. The Pentagon also provided $150m to LeoLabs. Space Systems Command forecasts 249 medium- and heavy-class launches by the early 2030s, up from previous estimates.

$GGGMed

Graco Enters $600 Million Accelerated Share Repurchase Agreement

Graco (GGG) initiated a $600M accelerated share repurchase, covering 5% of its outstanding shares. The company will use cash and borrowings from its revolving credit facility. Initial retirement of 6.9M shares is expected, with final numbers based on stock's average price. Settlement is due in March 2027, with 17M shares remaining under repurchase authorization.